Innoviva Company Profile (NASDAQ:THRX)

About Innoviva (NASDAQ:THRX)

Innoviva logoInnoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate (FF)/vilanterol (VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement and the Strategic Alliance Agreement with GSK, the Company is eligible to receive the annual royalties from GSK on sales of RELVAR/BREO ELLIPTA. For other products combined with a LABA from the LABA collaboration, such as ANORO ELLIPTA, royalties are upward tiering and range from 6.5% to 10%. RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of a LABA (VI) and an inhaled corticosteroid (ICS), FF. ANORO ELLIPTA a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:THRX
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $9.81
  • 200 Day Moving Avg: $11.67
  • 52 Week Range: $6.36 - $21.16
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 32.70
  • P/E Growth: 0.00
Misc:
  • Average Volume: 867,484 shs.
 

Frequently Asked Questions for Innoviva (NASDAQ:THRX)

What is Innoviva's stock symbol?

Innoviva trades on the NASDAQ under the ticker symbol "THRX."

Who are some of Innoviva's key competitors?

Who owns Innoviva stock?

Innoviva's stock is owned by a variety of of retail and institutional investors. Top institutional investors include GLAXOSMITHKLINE PLC (29.30%). View Institutional Ownership Trends for Innoviva.

How do I buy Innoviva stock?

Shares of Innoviva can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Innoviva stock cost?

One share of Innoviva stock can currently be purchased for approximately $9.81.

Analyst Ratings

Consensus Ratings for Innoviva (NASDAQ:THRX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Innoviva (NASDAQ:THRX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/2/2016Morgan StanleyReiterated RatingSell$7.00N/AView Rating Details
(Data available from 5/23/2015 forward)

Earnings

Earnings History for Innoviva (NASDAQ:THRX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Innoviva (NASDAQ:THRX)
Current Year EPS Consensus Estimate: $-0.19 EPS
Next Year EPS Consensus Estimate: $0.30 EPS

Dividends

Dividend History for Innoviva (NASDAQ:THRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Innoviva (NASDAQ:THRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Innoviva (NASDAQ:THRX)
Latest Headlines for Innoviva (NASDAQ:THRX)
Source:
DateHeadline
americanbankingnews.com logoInnoviva (THRX) Earning Positive Media Coverage, Report Shows
www.americanbankingnews.com - May 3 at 8:38 PM
americanbankingnews.com logoFavorable News Coverage Somewhat Unlikely to Impact Innoviva (THRX) Stock Price
www.americanbankingnews.com - April 27 at 7:48 PM
americanbankingnews.com logoInnoviva (THRX) Receives Media Sentiment Score of 0.31
www.americanbankingnews.com - April 24 at 5:32 PM
americanbankingnews.com logoInnoviva (THRX) Earning Positive Media Coverage, Study Finds
www.americanbankingnews.com - April 17 at 4:39 PM
americanbankingnews.com logoSomewhat Positive News Coverage Very Unlikely to Impact Innoviva (THRX) Stock Price
www.americanbankingnews.com - April 14 at 4:53 PM
usatoday.com logoCruise Ship Heading From Miami to Havana
www.usatoday.com - May 2 at 5:29 AM
foxnews.com logoBodies of elite climber, cameraman found in melting Himalayan glacier
www.foxnews.com - May 2 at 5:29 AM
abcnews.go.com logoParamedic Says 'Yes' to Cop's Proposal Caught on Dash Cam
abcnews.go.com - May 1 at 7:12 PM
nytimes.com logoPete Wilson of California Backs Ted Cruz and Warns of Donald Trump
www.nytimes.com - April 30 at 11:42 PM
usatoday.com logoRacist texts prompt anti-bias training for San Francisco police
www.usatoday.com - April 30 at 6:34 PM
usatoday.com logo'Fargo' Cast Celebrate With Emmy Voters
www.usatoday.com - April 29 at 6:45 PM
foxnews.com logoAuthorities say death at Apple headquarters was suicide
www.foxnews.com - April 29 at 12:04 AM
cnn.com logoDespite Cruz pact, Indiana paper backs Kasich in bid to stop Trump
www.cnn.com - April 29 at 12:04 AM
nytimes.com logoMissing Money, a Vicious Attack and Slow Healing for a Charity’s Leader
www.nytimes.com - April 28 at 6:57 PM
nbcnews.com logoE-Cigarettes Can Help Smokers Quit, U.K. Doctors Say
www.nbcnews.com - April 28 at 6:57 PM
finance.yahoo.com logoInnoviva meets 1Q profit forecasts
finance.yahoo.com - April 28 at 5:25 PM
fool.com logoThe 3 Most Important Numbers When GlaxoSmithKline Reports Its Fourth-Quarter Results
www.fool.com - January 29 at 2:02 PM
finance.yahoo.com logoTheravance, Inc. Announces Name Change to Innoviva, Inc.
finance.yahoo.com - January 8 at 8:00 AM
fool.com logoWill 2016 Be GlaxoSmithKline plc's Best Year Yet?
www.fool.com - January 4 at 9:59 AM
fool.com logoThe Best GlaxoSmithKline plc Headlines in 2015
www.fool.com - December 28 at 2:34 PM

Social

Chart

Innoviva (THRX) Chart for Tuesday, May, 23, 2017

This page was last updated on 5/23/2017 by MarketBeat.com Staff